3rd Joint Transnational Call for Proposals (2020)

Basic Information


Network ERA PerMed
Website https://www.erapermed.eu/joint-calls/joint-transnational-call-2020/
Aim of the joint call The overall objectives of the call are to: - Support translational research projects in the field of Personalised Medicine; - Encourage and enable interdisciplinary collaborations towards the implementation of PM, combining pre-clinical and/or clinical research with bioinformatics components and research on relevant ethical, legal and social aspects and/or research on the optimisation of health care systems; - Encourage collaboration between academia (research teams from universities, higher education institutions, public research institutions), clinical/public health research (research teams from hospital/ public health, health care settings and other health care organisations), private partners e.g. SMEs (small and medium-sized enterprises) as well as policy makers, regulatory/HTA agencies and patient organisations.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Launch date 16/12/2019
Deadline Pre-Proposal 05/03/2020 Submitted proposal: 188
Deadline Full-Proposal 15/06/2020 Submitted proposal: 52
Evaluation End Date 15/10/2020 Successful proposal: 0 Proposals funded: 18
Is call co-funded? No
Call follow up funding
  • There are mechanisms in place to monitor
Call reasons
  • Addressing specific scientific and technological issues
Research fields
  • Health
Type of research
  • Basic research
  • Applied Research
  • Pre-competitive research
Target groups
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
  • Large Corporations
Participating networks n/a

Organisations Participating

Country Organisation
Belgium National Fund for Scientific Research (FNRS)
Canada Quebec Research Fund - Health (FRQS)
Croatia Ministry of Science, Education and Sports (MSES-MZOS)
Denmark Innovation Fund Denmark (Innofond)
Egypt Academy of Scientific Research and Technology (ASRT)
Finland Academy of Finland (AKA)
France National Research Agency (ANR)
Germany Federal Ministry of Education and Research (BMBF)
Germany Federal Ministry of Health (BMG)
Germany German Aerospace Center (DLR)
Germany Saxon State Ministry for science, culture and tourism (SMWK)
Germany VDI/VDE Innovation + Technik GmbH (VDI/VDE-IT)
Greece General Secretariat for Research and Technology (GSRT)
Hungary National Research, Development and Innovation Office (NKFIH)
Ireland Health Research Board (HRB)
Israel Ministry of Health (CSO-MOH)
Italy Lombardy Foundation for Biomedical Research (FRRB)
Italy Ministry of Health (MOH/MDS)
Italy Tuscany Region (TOS)
Latvia State Education Development Agency (VIAA)
Luxembourg National Fund for Research (FNR)
Norway Research Council of Norway (RCN)
Panama Secretariat of Science, Technology and Innovation (SENACYT)
Poland National Centre for Research and Development (NCBiR)
Romania Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI)
Slovenia Ministry of Education, Science, Culture and Sport (MESCS/MIZS)
Spain Centre for the Development of Industrial Technology (CDTI)
Spain Government of Navarra (CFN)
Spain Institute of Health Carlos III (ISCIII)
Spain Spanish Association Against Cancer Scientific Foundation (AECC FC)
Sweden Swedish Research Council (VR/SRC)
Türkiye The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym Title Start End No. partners
CLL-CLUE Tailoring the targeted treatment of chronic lymphocytic leuk... 6
DECODE Defining stratification of patients with C3 Glomerulopathies... 6
DIGIPD Validating DIGItal biomarkers for better personalized treatm... 6
EV-glio Plasma extracellular vesicles (EVs): the key for precision m... 6
HiRisk-HiGain Rethinking personalized cancer therapy: targeting minimal r... 6
MSOP-PRE Early PREdiction and personalized PREvention of Metabolic Sy... 5
ONCOLOGICS Computational modelling and functional validation platform f... 6
OptiCAN Optimized T cells for personalized immunotherapy for solid c... 4
PARIS Precision drugs Against Resistance In Subpopulations 6
PMT-LC Personalized multimodal therapies for the treatment of lung ... 5
PROGRESS PRecisiOn medicine in CAD patients: artificial intelliGence ... 5
PROMPT Toward PrecisiOn Medicine for the Prediction of Treatment re... 7
PerEpi Personalised diagnosis and treatment for refractory focal pa... 4
PerMIDRIAR Personalized medicine to tackle immune dysfunction in refrac... 5
PerPlanRT Personalized planning in radiotherapy through integrative ... 6
Preserve AI for new signatures and models for tailored organ preserva... 6
RESPECT Renal MRI standardization to improve personalised management... 6
TIPS Tailored Immunotherapy for Paediatric SIRS (severe inflammat... 5